Related Experiment Videos
Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathway
Thomas R Hawn1, Adrian Ozinsky, David M Underhill
1Division of Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Abstract:
Leishmania species present unusual challenges to the immune system with their capacity to downregulate inflammatory responses as well as their ability to live within macrophages. Although toll-like receptor (TLR) pathways have been implicated in the recognition of several classes of pro-inflammatory microbes, it is not known if pathogens with anti-inflammatory properties activate the host response through this family of proteins. In this study, Leishmania major stimulation of cytokine promoter-luciferase reporter constructs was examined in transfected macrophages to detect early signs of cellular activation. L. major selectively activated the promoter region of IL-1 alpha, but not IL-6, IL-8, IL-10, or an NF-kappa B reporter. IL-1 alpha mRNA expression was also stimulated by L. major, although at lower levels than lipopolysacharide-stimulated macrophages. No IL-1 alpha protein was detectable in stimulated cell lysates or culture supernatants. Transfection of macrophages with a dominant-negative version of myeloid differentiation factor 88 (MyD88), an adaptor protein which interacts with TLRs, inhibited activation of the IL-1 alpha promoter. Furthermore, stimulation of IL-1 alpha RNA expression by L. major was inhibited in peritoneal macrophages from MyD88-/- as compared to MyD88+/+ mice. These observations indicate that L. major stimulates IL-1 alpha promoter activity and mRNA expression in macrophages through MyD88-dependent pathways. However, additional anti-inflammatory pathways must also be activated which downregulate transcription and ultimately inhibit translation of the IL-1 alpha protein. Examination of promoter activation is a powerful tool for understanding the early events in macrophage activation for anti-inflammatory pathogens such as Leishmania that have mechanisms to downregulate transcription and translation.
Insights
Leishmania major activates the IL-1 alpha promoter and mRNA via MyD88-dependent pathways in macrophages. However, the parasite employs additional mechanisms to suppress IL-1 alpha protein production, highlighting its anti-inflammatory strategies.
Area of Science:
- Immunology
- Molecular Biology
- Parasitology
Background:
- Leishmania species evade host immunity by downregulating inflammation and residing within macrophages.
- Toll-like receptor (TLR) pathways are crucial for recognizing microbes, but their role in anti-inflammatory pathogens like Leishmania is unclear.
Purpose of the Study:
- To investigate whether Leishmania major activates host immune responses through TLR pathways.
- To identify early cellular activation events in macrophages stimulated by L. major.
Main Methods:
- Utilized cytokine promoter-luciferase reporter constructs in transfected macrophages to assess cellular activation.
- Examined IL-1 alpha mRNA expression and protein levels following L. major stimulation.
- Employed dominant-negative myeloid differentiation factor 88 (MyD88) and MyD88 knockout macrophages to investigate MyD88-dependent signaling.
Main Results:
- L. major selectively activated the IL-1 alpha promoter and mRNA expression, but not IL-6, IL-8, IL-10, or NF-kappa B reporters.
- IL-1 alpha mRNA stimulation was MyD88-dependent, as confirmed by experiments with dominant-negative MyD88 and MyD88-/- macrophages.
- No detectable IL-1 alpha protein was found, suggesting post-transcriptional regulation by L. major.
Conclusions:
- L. major initiates macrophage activation via MyD88-dependent pathways, specifically targeting IL-1 alpha promoter and mRNA.
- The parasite employs additional anti-inflammatory mechanisms to inhibit IL-1 alpha translation, enabling immune evasion.
- Analyzing promoter activation is key to understanding macrophage responses to anti-inflammatory pathogens like Leishmania.